Data were presented by Karen Reckamp, MD, Associate Professor of Medical Oncology at the City of Hope Comprehensive Cancer Center.
What does COHCCC stand for?
COHCCC stands for City of Hope Comprehensive Cancer Center (Beckman Research Institute; Duarte, California)
This definition appears rarely and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
- Organizations, NGOs, schools, universities, etc.
- Co-Operation on Health and Biodiversity (County Galway, Ireland, UK)
- Conference on Health and Biodiversity
- Central Oklahoma Home Builders Association
- Central Ohio Heritage Circle
- Certified Occupational Hearing Conservationist
- Chemistry of Heterocyclic Compounds (journal)
- Citic Offshore Helicopter Co., Ltd. (China)
- City of Oxford Hockey Club
- Cost of Health Care
- Center for Oral History and Cultural Heritage (University of Southern Mississippi)
- Consejo Hondureño de Ciencia y Tecnología (Spanish: Honduran Council of Science and Technology)
- College of Health Deans
- College of Humanities and Development (China)
- Center of Occupational Health and Education (Washington)
- College of Osteopathic Healthcare Executives (American College of Healthcare Executives)
- Commission On Higher Education
- Continuum of Humanist Education
- Control of Hazardous Energy
- Coalition of Higher Education Assistance Organizations
Samples in periodicals archive:
The researchers for the study examined the prevalence and severity of chronic health conditions reported by 1,022 HCT survivors who received their transplants at City of Hope Comprehensive Cancer Center, Duarte, CA, or the University of Minnesota between 1974 and 1998 for a blood cancer or severe aplastic anemia.
The family requests that those who wish to make a memorial donation send it to The City of Hope Comprehensive Cancer Center (Duarte) or the USC/Norris Comprehensive Cancer Center and Hospital (Los Angeles).
The company is currently preparing to enter IT-101 into human clinical trials at the City of Hope Comprehensive Cancer Center in Duarte, Calif.
Stephen Shibata at the City of Hope Comprehensive Cancer Center in Duarte California, together with Dr.
Insert) a majority-owned subsidiary of Arrowhead Research Corporation (Nasdaq:ARWR) & (Nasdaq:ARWRW), announced today that Insert is planning with City of Hope Comprehensive Cancer Center a broad-based Phase I clinical trial for Insert's lead drug candidate, a combination of its patented polymer technology, Cyclosert(TM), and the anti-cancer compound camptothecin.